We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Top Ranked Momentum Stocks to Buy for October 22nd
Read MoreHide Full Article
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, October 22nd:
Cambium Networks Corporation (CMBM - Free Report) : This wireless broadband networking infrastructure products and solutions provider has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 15.4% over the last 60 days.
Cambium Networks Corp’s shares gained 30% over the last one month compared with the S&P 500’s growth of 4.7%. The company possesses a Momentum Score of A.
Janus Henderson Group plc (JHG - Free Report) : This asset management holding entity has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 2.8% over the last 60 days.
National Beverage Corp. (FIZZ - Free Report) : This sparkling waters, juices, energy drinks, and carbonated soft drinks manufacturer has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 27.7% over the last 60 days.
Boyd Gaming Corporation (BYD - Free Report) : This multi-jurisdictional gaming company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 20.7% over the last 60 days.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
Image: Bigstock
Top Ranked Momentum Stocks to Buy for October 22nd
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, October 22nd:
Cambium Networks Corporation (CMBM - Free Report) : This wireless broadband networking infrastructure products and solutions provider has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 15.4% over the last 60 days.
Cambium Networks Corporation Price and Consensus
Cambium Networks Corporation price-consensus-chart | Cambium Networks Corporation Quote
Cambium Networks Corp’s shares gained 30% over the last one month compared with the S&P 500’s growth of 4.7%. The company possesses a Momentum Score of A.
Cambium Networks Corporation Price
Cambium Networks Corporation price | Cambium Networks Corporation Quote
Janus Henderson Group plc (JHG - Free Report) : This asset management holding entity has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 2.8% over the last 60 days.
Janus Henderson Group plc Price and Consensus
Janus Henderson Group plc price-consensus-chart | Janus Henderson Group plc Quote
Janus Henderson Group’s shares gained 40.6% over the last one month. The company possesses a Momentum Score of B.
Janus Henderson Group plc Price
Janus Henderson Group plc price | Janus Henderson Group plc Quote
National Beverage Corp. (FIZZ - Free Report) : This sparkling waters, juices, energy drinks, and carbonated soft drinks manufacturer has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 27.7% over the last 60 days.
National Beverage Corp. Price and Consensus
National Beverage Corp. price-consensus-chart | National Beverage Corp. Quote
National Beverage Corp’s shares gained 22.8% over the last one month. The company possesses a Momentum Score of A.
National Beverage Corp. Price
National Beverage Corp. price | National Beverage Corp. Quote
Boyd Gaming Corporation (BYD - Free Report) : This multi-jurisdictional gaming company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 20.7% over the last 60 days.
Boyd Gaming Corporation Price and Consensus
Boyd Gaming Corporation price-consensus-chart | Boyd Gaming Corporation Quote
Boyd Gaming’s shares gained 23.5% over the last one month. The company possesses a Momentum Score of A.
Boyd Gaming Corporation Price
Boyd Gaming Corporation price | Boyd Gaming Corporation Quote
See the full list of top ranked stocks here.
Learn more about the Momentum score and how it is calculated here.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>